Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Jaguarhealth.gcs-web.com save search
Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
Published: 2023-01-30 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: -3.53%
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -1.06%
H: 1.94%
C: 0.0%
fda health
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, January 16th During the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida
Published: 2022-01-12 (Crawled : 16:20) - jaguarhealth.gcs-web.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.0%
H: 0.0%
C: 0.0%
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 12.9%
H: 0.0%
C: 0.0%
veterinarians treatment health conference diarrhea therapy
Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Published: 2023-02-01 (Crawled : 14:00) - jaguarhealth.gcs-web.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 1.76%
H: 0.0%
C: -1.72%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.86%
H: 1.73%
C: 1.08%
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 3.97%
H: 1.7%
C: -3.61%
health
Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
Published: 2023-04-06 (Crawled : 13:00) - jaguarhealth.gcs-web.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.65%
H: 0.06%
C: -1.52%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -2.29%
H: 1.57%
C: 1.4%
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 0.02%
H: 1.74%
C: -5.26%
health update
Jaguar Health Announces Incorporation of Napo EU Subsidiary in Italy
Published: 2021-03-15 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 4.98%
H: 1.4%
C: -1.23%
health
Jaguar Health Announces Winner of International Day of Forests Contest
Published: 2021-03-22 (Crawled : 14:15) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.74%
test health
Jaguar Health Announces Upsizing of At-the-Market (ATM) Financing Program by $15.3 Million with Ladenburg Thalmann & Co. Inc. for Potential Future Financing Needs
Published: 2021-04-15 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -2.6%
H: 1.46%
C: -14.34%
potential
Jaguar Health Enters Binding Term Sheet for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue Stream
Published: 2021-03-05 (Crawled : 14:11) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 1.86%
H: 4.88%
C: -2.44%
covid potential crofelemer
Jaguar Health Signs Definitive Agreement for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue Stream
Published: 2021-03-09 (Crawled : 13:33) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 7.37%
H: 1.29%
C: -6.44%
covid potential crofelemer
Jaguar Health Announces Amendment to March 2020 Equity Purchase Agreement with Oasis Capital, LLC
Published: 2021-04-08 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 4.28%
H: 1.03%
C: -0.51%
health
Jaguar Health Reports 2020 Financial Results and Business Updates
Published: 2021-03-31 (Crawled : 21:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 19.83%
H: 0.14%
C: -8.21%
financial results results health
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-04-02 (Crawled : 17:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
| Email alert
Add to watchlist
granted health grant
Jaguar Health Announces Selection of Investment Bank and Nominated Advisor for Proposed Merger of the Dragon SPAC and Napo EU, Jaguar's Italian Subsidiary
Published: 2021-03-30 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 0.58%
H: 3.51%
C: 1.16%
spac merge
Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated with Cancer Therapy-Related Diarrhea Accepted for Poster Presentation at the American Society of Clinical Oncology 2021 Annual Meeting
Published: 2021-04-29 (Crawled : 12:15) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -4.22%
H: 5.03%
C: -4.4%
presentation tcom diarrhea therapy cancer
Jaguar Health Announces $10.8 Million Registered Direct Offering for the Benefit of Napo EU Business Plan
Published: 2021-04-29 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -4.22%
H: 5.03%
C: -4.4%
offering health
REMINDER FROM JAGUAR HEALTH: Innovators with Jane King Webcast Interview to Take Place Friday, April 23, 2021 at 8:30 AM Eastern to Provide a Business Overview of Napo EU S.p.A., Jaguar’s New Italian Subsidiary
Published: 2021-04-21 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: -1.61%
H: 13.11%
C: 11.48%
Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting
Published: 2021-05-20 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 0.0%
H: 5.04%
C: 5.04%
diarrhea cancer
Napo Pharmaceuticals, Jaguar Health’s Subsidiary, Bolsters Management Team with Appointment of Darlene Horton, M.D. as Chief Medical Officer
Published: 2021-05-26 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 2.63%
H: 14.1%
C: 8.97%
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
Published: 2021-06-01 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 3.12%
H: 14.55%
C: 9.09%
authorized
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
Published: 2021-06-01 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 3.12%
H: 14.55%
C: 9.09%
funding spac health
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.